CNGA2: Target/Biomarker Introduction, products summarized (antibody/ADC/bispecific/antigen/ORF vector/VLP) and disease/indication/condition/MOA for drug discovery and IVD
It’s the GeneMedi’s summary page for Target/Biomarker Introduction of CNGA2. The page also collects GeneMedi’s different modalities and formats products for CNGA2 in therapeutics/drug discovery and IVD diagnostics, which is including antibody, ADC, bispecific, antigen, ORF vector, VLP, etc. With GeneMedi’s target-insight database-GM ITD database, the CNGA2 target is also connected to human indications/diseases/conditions/MOA.
Target sublocation: Transmembrane Protein.
The protein encoded by this gene represents the alpha subunit of a cyclic nucleotide-gated olfactory channel. The encoded protein contains a carboxy-terminal leucine zipper that mediates channel formation. [provided by RefSeq, Jan 2010]
|
Target ID |
GM-T34204
|
|
Target Name |
CNGA2
|
|
Gene ID |
1260
|
|
Gene Official Name |
CNGA2
|
|
Gene Alias |
CNCA, CNCA1, CNG2, OCNC1, OCNCALPHA, OCNCa
|
|
Protein Sub-location |
Transmembrane Protein
|
|
Category |
Therapeutics Target
|
Anti-CNGA2/ CNCA/ CNCA1 antibody for FACS & in-vivo assay| GMab
Pre-made anti-CNGA2 benchmark inhibitory monoclonal antibody(mab, blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). The anti-CNGA2 mab is expressed and produced by mammalian cell line as a benchmark reference therapeutic antibody for biological drug discovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Warning: Undefined array key "category" in /www/wwwroot/genemedi_com0630/wp-content/plugins/wc-product-table-pro/pro/functions.php on line 2278
